SAkuraSky study shows satralizumab reduces relapse of neuromyelitis optica in AQP4-IgG+ patients May 23, 2019
FDA approves Nayzilam to treat intermittent, stereotypic episodes of frequent seizure activity May 21, 2019
Allergan presents phase III results from ACHIEVE II study of ubrogepant for treating migraine May 21, 2019
RSS